The Effects of the Affordable Care Act on Stem Cell Transplant
FRIDAY, SEPT. 12, 2014
Stephanie Farnia, MPH, National Marrow Donor Registry (NMDP) / Be the Match
Our current health care environment is complex with new laws and changes. The Patient Protection and Affordable Care Act, commonly called the Affordable Care Act (ACA), was signed into law in 2010, with most of the health care provisions going into effect during 2014. The ACA was designed to increase access, improve quality, and control health care costs. As a result of the ACA, SCT patients may be impacted more quickly and to a greater degree than average health care consumers. This presentation will discuss how the ACA will impact SCT patients and the role it plays from patients’ and providers’ perspectives.
- Review the ACA implementation and design that are impacting SCT.
- Describe non-ACA changes and issues impacting SCT.
- Evaluate how the ACA and non-ACA health care provisions are impacting SCT.
These materials are intended ONLY for pharmacists and pharmacy technicians that attended the presentation, "The Effects of the Affordable Care Act on Stem Cell Transplant" held at 10:00 a.m. Friday, Sept. 12, 2014. This session was part of the "23rd Annual National Conference" held in Chicago, Ill. on Sept. 10-12, 2014.
The prerequisite to this process is completing the 23rd Annual National Conference Post-Assessment and Evaluation. If there is a Prerequisite section above and the Status field is blank, click on '23rd Annual National Conference' to open the Assessment and Evaluation.
- 0.75 ACPE - Pharmacists